US Digital Diabetes Management Market $22.67 billion by 2031
The report "US Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Global Forecast to 2031" is projected to grow from USD 22.67 billion by 2031 and to reach USD 12.94 billion in 2026, at a Compound Annual Growth Rate (CAGR) of 11.9% during the forecast period.
Browse 150 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "US Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-digital-diabetes-management-market-118903465.html
In the US, the digital diabetes management market is driven by the increasing prevalence of diabetes, growing adoption of continuous glucose monitoring and connected insulin delivery devices, and strong patient preference for self-care and home care. Favorable reimbursement policies, high digitalization of health care services, and extensive penetration of smartphones have also favored the adoption of more web-based health solutions. More integration of analytics powered with AI, telehealth platforms, and interoperable ecosystems enhances clinical outcomes and patient engagement. Rising awareness about preventive care and models of value-based healthcare are also speeding up the demand for digital diabetes solutions across the US.
The Continuous Glucose Monitoring (CGM) systems segment held the largest share in the US digital diabetes management market, by product & service, in 2025.
The product & service segment includes devices, digital diabetes management apps, data management software & platforms, and services. The devices segment includes CGM systems, smart insulin pens, smart insulin pumps/closed-loop systems, smart insulin patches, and smart glucose meters. Through constant innovation, CGM has improved accuracy, extended life, wearability, and user-friendliness. Modern CGMs come with factory-calibrated extended-wear cables that link to smartphones and alert in real-time, eliminating the need for frequent finger pricks. With these new features, CGM has become the preferred monitoring method due to its adoption trend compared to conventional glucose monitoring options, demonstrating its leadership.
In 2025, the self/home healthcare segment accounted for the largest share of the US digital diabetes management market, by end user.
Patients in the US are aware of the complications due to diabetes, and they show intense preference for a proactive self-management model for achieving good glycemic control. Digital platforms offer personalized insights, alerts, and educational materials, enabling patients to make informed decisions about their lifestyle and treatment. The emerging trend of a preference for more autonomy in managing and self-monitoring consistently elicits demand for home-based digital diabetes management solutions. This is expected to help lead the self/home healthcare segment in the US digital diabetes management market, by end user.
Key Market Players
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Health2Sync (Taiwan), Tandem Diabetes Care (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Ascensia Diabetes Care Holdings AG (Switzerland), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), Pendiq GmbH (Germany), One Drop (US), Decide Clinical Software GmbH (Austria), and BeatO (India).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the US Digital Diabetes Management Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
